In an interview by Xtalks, Dr. David Cameron, Chair of the Breast International Group (BIG), shared valuable insights into the current state of breast cancer research, emphasizing the role of clinical trials and the integration of patient perspectives in research. BIG's efforts, as outlined by Dr. Cameron, represent a substantial leap forward in understanding and treating breast cancer, with a strong emphasis on global collaboration and patient involvement.
TORONTO, Dec. 5, 2023 /PRNewswire-PRWeb/ -- In an exclusive interview, Xtalks delves into the current state of breast cancer research, highlighting the role of clinical trials and the integration of patient perspectives in clinical research. Featuring Dr. David Cameron, Chair of the Breast International Group (BIG), the discussion revolves around the importance of collaboration and patient involvement in breast cancer clinical research.
Dr. Cameron emphasized the importance of international collaboration in advancing breast cancer research. BIG, as the leading global network of academic breast clinical trialists, is spearheading international efforts to innovate treatment options and
understand the complexities of breast cancer.
In the interview, Dr. Cameron highlighted the diverse nature of breast cancer and the resulting complexities in patient enrollment for clinical trials. Challenges include varying availability of trials, changing treatment philosophies, the complexity of the disease and the influence of public perception.
BIG has long valued the patient perspective, including them in trial steering groups. Dr. Cameron advocates for a more profound inclusion, where patients influence not just how trials are conducted but also which trials are pursued. This approach ensures that research aligns with patient priorities and questions.
Recognizing the global strides in involving patients in research, BIG is committed to a patient-centric approach. This includes international collaboration to shape trial questions and providing mentorship and training for patients to engage effectively in the research process.
BIG's efforts, as outlined by Dr. Cameron, represent a significant leap forward in understanding and treating breast cancer, with a strong emphasis on global collaboration and patient involvement.
To read the full interview, visit Amplifying Patient Voices in Breast Cancer Clinical Trials.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]